91 related articles for article (PubMed ID: 27466953)
1. MHC Class II Binding Prediction by Molecular Docking.
Atanasova M; Dimitrov I; Flower DR; Doytchinova I
Mol Inform; 2011 Apr; 30(4):368-75. PubMed ID: 27466953
[TBL] [Abstract][Full Text] [Related]
2. Peptide binding prediction for the human class II MHC allele HLA-DP2: a molecular docking approach.
Patronov A; Dimitrov I; Flower DR; Doytchinova I
BMC Struct Biol; 2011 Jul; 11():32. PubMed ID: 21752305
[TBL] [Abstract][Full Text] [Related]
3. EpiDOCK: a molecular docking-based tool for MHC class II binding prediction.
Atanasova M; Patronov A; Dimitrov I; Flower DR; Doytchinova I
Protein Eng Des Sel; 2013 Oct; 26(10):631-4. PubMed ID: 23661105
[TBL] [Abstract][Full Text] [Related]
4. Quantitative prediction of peptide binding to HLA-DP1 protein.
Ivanov S; Dimitrov I; Doytchinova I
IEEE/ACM Trans Comput Biol Bioinform; 2013; 10(3):811-5. PubMed ID: 24091413
[TBL] [Abstract][Full Text] [Related]
5. A pattern search method for putative anchor residues in T cell epitopes.
Hobohm U; Meyerhans A
Eur J Immunol; 1993 Jun; 23(6):1271-6. PubMed ID: 7684684
[TBL] [Abstract][Full Text] [Related]
6. Functional mapping of MHC class II polymorphic residues. The alpha-chain controls the specificity for binding an Ad-versus an A k-restricted peptide and the beta-chain region 65-67 controls T cell recognition but not peptide binding.
Lee JM; McKean DJ; Watts TH
J Immunol; 1991 May; 146(9):2952-9. PubMed ID: 1849939
[TBL] [Abstract][Full Text] [Related]
7. Characterizing immunodominant and protective influenza hemagglutinin epitopes by functional activity and relative binding to major histocompatibility complex class II sites.
Rajnavölgyi E; Horváth A; Gogolák P; Tóth GK; Fazekas G; Fridkin M; Pecht I
Eur J Immunol; 1997 Dec; 27(12):3105-14. PubMed ID: 9464794
[TBL] [Abstract][Full Text] [Related]
8. Presentation of a horse cytochrome c peptide by multiple H-2b class I major histocompatibility complex (MHC) molecules to C57BL/6- and bm1-derived cytotoxic T lymphocytes: presence of a single MHC anchor residue may confer efficient peptide-specific CTL recognition.
Sheil JM; Schell TD; Shepherd SE; Klimo GF; Kioschos JM; Paterson Y
Eur J Immunol; 1994 Sep; 24(9):2141-9. PubMed ID: 7522163
[TBL] [Abstract][Full Text] [Related]
9. Comparison of structural requirements for interaction of the same peptide with I-Ek and I-Ed molecules in the activation of MHC class II-restricted T cells.
Leighton J; Sette A; Sidney J; Appella E; Ehrhardt C; Fuchs S; Adorini L
J Immunol; 1991 Jul; 147(1):198-204. PubMed ID: 1711074
[TBL] [Abstract][Full Text] [Related]
10. T cell recognition of MHC class II-associated peptides is independent of peptide affinity for MHC and sodium dodecyl sulfate stability of the peptide/MHC complex. Effects of conservative amino acid substitutions at anchor position 1 of influenza matrix protein19-31.
Wu S; Gorski J; Eckels DD; Newton-Nash DK
J Immunol; 1996 May; 156(10):3815-20. PubMed ID: 8621918
[TBL] [Abstract][Full Text] [Related]
11. Toward the prediction of class I and II mouse major histocompatibility complex-peptide-binding affinity: in silico bioinformatic step-by-step guide using quantitative structure-activity relationships.
Hattotuwagama CK; Doytchinova IA; Flower DR
Methods Mol Biol; 2007; 409():227-45. PubMed ID: 18450004
[TBL] [Abstract][Full Text] [Related]
12. Peptide Binding Prediction to Five Most Frequent HLA-DQ Proteins - a Proteochemometric Approach.
Dimitrov I; Doytchinova I
Mol Inform; 2015 Jun; 34(6-7):467-76. PubMed ID: 27490390
[TBL] [Abstract][Full Text] [Related]
13. Interactions between immunogenic peptides and MHC proteins.
Rothbard JB; Gefter ML
Annu Rev Immunol; 1991; 9():527-65. PubMed ID: 1910688
[TBL] [Abstract][Full Text] [Related]
14. Structural principles that govern the peptide-binding motifs of class I MHC molecules.
Zhang C; Anderson A; DeLisi C
J Mol Biol; 1998 Sep; 281(5):929-47. PubMed ID: 9719645
[TBL] [Abstract][Full Text] [Related]
15. Docking-Based Prediction of Peptide Binding to MHC Proteins.
Atanasova M; Doytchinova I
Methods Mol Biol; 2023; 2673():237-249. PubMed ID: 37258919
[TBL] [Abstract][Full Text] [Related]
16. Prediction of promiscuous and high-affinity mutated MHC binders.
Bhasin M; Raghava GP
Hybrid Hybridomics; 2003 Aug; 22(4):229-34. PubMed ID: 14511568
[TBL] [Abstract][Full Text] [Related]
17. Peptide binding specificity of major histocompatibility complex class I resolved into an array of apparently independent subspecificities: quantitation by peptide libraries and improved prediction of binding.
Stryhn A; Pedersen LO; Romme T; Holm CB; Holm A; Buus S
Eur J Immunol; 1996 Aug; 26(8):1911-8. PubMed ID: 8765039
[TBL] [Abstract][Full Text] [Related]
18. Quantitative prediction of MHC-II binding affinity using particle swarm optimization.
Zhang W; Liu J; Niu Y
Artif Intell Med; 2010 Oct; 50(2):127-32. PubMed ID: 20541921
[TBL] [Abstract][Full Text] [Related]
19. Improved prediction of MHC class I and class II epitopes using a novel Gibbs sampling approach.
Nielsen M; Lundegaard C; Worning P; Hvid CS; Lamberth K; Buus S; Brunak S; Lund O
Bioinformatics; 2004 Jun; 20(9):1388-97. PubMed ID: 14962912
[TBL] [Abstract][Full Text] [Related]
20. Toward prediction of class II mouse major histocompatibility complex peptide binding affinity: in silico bioinformatic evaluation using partial least squares, a robust multivariate statistical technique.
Hattotuwagama CK; Toseland CP; Guan P; Taylor DJ; Hemsley SL; Doytchinova IA; Flower DR
J Chem Inf Model; 2006; 46(3):1491-502. PubMed ID: 16711768
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
